コレチストキニンの鎮痛剤:安全性に関する注意事項により,モルヒンの鎮痛剤を廃止する
関連する実験動画
Updated: Jul 18, 2026

07:09
The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
E P Wiertelak1, S F Maier, L R Watkins
1Department of Psychology, University of Colorado, Boulder 80309.
まとめ
安全信号は,脊髄にある神経ペプチドコレシストキニンを活性化させ,モルヒネを逆行させ,痛み緩和を阻害する.
科学分野:
- 神経科学は神経科学である.
- 痛みの研究 痛みの研究
- オピエイト薬理学 オピエイト薬理学
背景:
- 危険を警告する環境的シグナルは,内生的な痛み緩和システムを活性化させます.
- 反対に,安全性を示すヒントは,これらの痛み緩和メカニズムを阻害する.
研究 の 目的:
- 安全信号がモルヒン誘発の鎮痛にどのように影響するかを調査する.
- 安全信号の鎮痛効果の基礎となる神経化学的メカニズムを特定する.
主な方法:
- モルヒネを脊髄に直接投与する.
- 安全性をシグナルする環境刺激への曝露.
- 鎮痛効果と神経ペプチドの放出の測定.
主要な成果:
- 安全性を示す環境刺激は,脊髄モルヒンの鎮痛効果を無効にしました.
- この抗疼痛効果は,脊髄におけるコレシストキニンの放出によって媒介された.
結論:
- 安全信号によって誘発される脊髄におけるコレチストキニンの放出は,オピエット鎮痛を抑制する.
- このメカニズムは,痛みの知覚の調節とオピエット耐性の発達に役割を果たす可能性があります.
関連する概念動画
Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...

